Skip to main content
KRMD
NASDAQ Industrial Applications And Services

KORU Medical Systems Extends Debt Maturities, Lowers Interest Rate Floor, and Gains Covenant Flexibility

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
7
Price
$4.32
Mkt Cap
$200.32M
52W Low
$1.86
52W High
$6.608
Market data snapshot near publication time

summarizeSummary

KORU Medical Systems amended its loan and security agreement, extending the maturity dates for its $5M revolving credit and $5M term loan facilities, lowering the interest rate floor, and replacing a restrictive financial covenant with a more flexible liquidity measure.


check_boxKey Events

  • Extended Debt Maturities

    The maturity of the $5,000,000 Revolver was extended from December 31, 2026, to March 30, 2028. The interest-only period for the $5,000,000 Term Loan was extended to June 30, 2027 (with a possible further extension to December 31, 2027), and its maturity was extended to December 1, 2029.

  • Lowered Interest Rate Floor

    The interest rate floor for both the Revolver and Term Loan facilities was lowered from 6.50% to 5.50%.

  • Improved Covenant Flexibility

    The adjusted quick ratio covenant was removed and replaced with a new remaining months liquidity covenant of at least twelve months, which is deemed compliant if the trailing three-month average Adjusted EBITDA is positive.

  • No Current Draw on Facility

    The company has not yet drawn on the $10,000,000 credit facility, maintaining future liquidity options.


auto_awesomeAnalysis

This amendment significantly enhances KORU Medical Systems' financial flexibility and extends its liquidity runway. By pushing out the maturity dates for both its revolving credit and term loan facilities, the company gains more time to manage its debt obligations. The reduction in the interest rate floor could lead to lower borrowing costs if the facilities are drawn upon. Furthermore, replacing the adjusted quick ratio covenant with a more flexible remaining months liquidity covenant, which includes an Adjusted EBITDA positive override, provides greater operational freedom and reduces the risk of covenant breaches. This move strengthens the company's balance sheet management, building on the improved financial health reported in its recent 10-K.

At the time of this filing, KRMD was trading at $4.32 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $200.3M. The 52-week trading range was $1.86 to $6.61. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed KRMD - Latest Insights

KRMD
Apr 09, 2026, 4:03 PM EDT
Filing Type: DEF 14A
Importance Score:
8
KRMD
Apr 03, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
KRMD
Mar 13, 2026, 9:44 PM EDT
Filing Type: 8-K
Importance Score:
8
KRMD
Mar 12, 2026, 5:10 PM EDT
Source: Reuters
Importance Score:
8
KRMD
Mar 12, 2026, 4:09 PM EDT
Filing Type: 10-K
Importance Score:
8
KRMD
Mar 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
KRMD
Feb 13, 2026, 4:56 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
KRMD
Jan 12, 2026, 10:25 AM EST
Filing Type: 8-K
Importance Score:
7